ISOFOL — Isofol Medical AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK309.14m
- SEK180.65m
- SEK0.72m
Annual cashflow statement for Isofol Medical AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -162 | -189 | -202 | -160 | -37.1 |
| Depreciation | |||||
| Non-Cash Items | 2.61 | 2.19 | -2.95 | -1.28 | -4.45 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 10.2 | 24.8 | 14.8 | -31.7 | -11.1 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -147 | -160 | -188 | -193 | -52.5 |
| Capital Expenditures | -0.324 | 0 | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | 0 | 0.101 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | -0.324 | 0 | — | 0 | 0.101 |
| Financing Cash Flow Items | — | — | — | 0.023 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.243 | 150 | 450 | 0.023 | 0 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -146 | -10.6 | 263 | -189 | -52.4 |